This approach was used to identify increases in the levels of serum amyloid protein A (SAA), C-reactive protein (CRP), adiponectin, and insulin-like growth factor binding protein 2 in patients with T1D [53]. This evidence concerns the gene SAA1 and type 1 diabetes mellitus.